Tenderwize
Retour à la recherche

Fremanezumab

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha·Praha - Břevnov, Czech Republic·CZK 31.3M | EUR 1.3M·Expired · Aug 07, 2026·Open·Supplies
High valueStructured notice only
Titre original de l'avis

Czechia – Analgesics – Fremanezumab

60/100

Score d'opportunité

Needs reviewLow complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

20 / 100

Facteurs de risque

No procurement documents were analyzed. Bidders must access documents via buyer profile to understand technical specifi...

Structured data marks the contract as EU-funded, but the XML notice indicates no EU funds. This could affect payment te...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Pays
République tchèque
CPV
33661200 - Analgesics
Date limite
Aug 07, 2026
Valeur estimée
CZK 31.3M (approx. EUR 1.3M)

Aperçu

Moderate opportunity

Faits clés

  • CZK 31.3M estimated value
  • Supplies contract
  • 1 lot
  • Duration 48 MONTH
  • Supply of Fremanezumab (analgesic) to the hospital in Prague
  • Duration: 48 months
Afficher le résumé complet

Open tender for the supply of the medicinal product Fremanezumab to the Central Military Hospital – Military University Hospital Prague for 48 months. Awarded based on lowest price (100% weight). Estimated value 31,300,948.80 CZK. Electronic submission required. Only one lot. No procurement documents were analyzed; only the published notice and XML are available.

Risques

No procurement documents were analyzed. Bidders must access documents via buyer profile to understand technical specifi...

Structured data marks the contract as EU-funded, but the XML notice indicates no EU funds. This could affect payment te...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Electronic submission required via the NEN profile
  • Bids submitted in Czech or Slovak (languages detected in notice)
  • Must provide the medicinal product Fremanezumab as specified in the procurement documents (not analyzed)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Price - 100% (weight code: per-exa) — 100%

Acheteur

Localisation

Praha - Břevnov, CZE

Site web

www.uvn.cz

Profil acheteur

Ouvrir le profil

Identifiant

61383082

Activité

Health

Lots (1)

LOT-0001

Fremanezumab

Supply of the medicinal product containing the active substance Fremanezumab for the Central Military Hospital – Military University Hospital Prague.

SuppliesEU fundedElectronic submission

EUR 1.3M

Valeur estimée

Localisation

CZ010, Czech Republic

Durée

48 MONTH

Catégorie

Analgesics

Critères d'attribution

Price

Date limite

Expired Aug 07, 2026

Détails de la procédure

Date de publication
06 Jul 2026
Langues
Czech

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
464950-2026

Documents (1)